MAINTENANCE--BUDESONIDE CONTROLLED ILEAL RELEASE CAPSULE IN CHRONS DISEASE

维持--布地奈德控制回肠释放胶囊治疗慢性疾病

• 批准号: 6279956
• 负责人: MARK A PEPPERCORN
• 金额: $ 2.49万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6279956
• 关键词: Crohn's disease; antiinflammatory agents; drug administration routes; drug screening /evaluation; gastrointestinal disorder chemotherapy; gastrointestinal function; glucocorticoids; human subject; human therapy evaluation; ileum; microcapsule

Maintenance continuation of a randomized, placebo controlled, multicenter clinical trial to investigate the efficacy and safety of budesonide CIR in patients with Crohn's Disease affecting the ileum and/or ascending colon.

随机、安慰剂对照的多中心维持治疗 布地奈德CIR治疗慢性阻塞性肺疾病的临床研究 影响回肠和/或升结肠的克罗恩病患者。